Suchergebnisse - "Lennox, Jeffrey L"

PubPharm (138)

71

Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence in antiretroviral-experienced women

enthalten in: AIDS (London, England) | 2010

von Kelley, C. | Sullivan, S. | Lennox, J. | +2

72

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection : week 96 results of the BENCHMRK 1 and 2 Phase III trials

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2010

von Steigbigel, R. | Cooper, D. | Teppler, H. | +120

73

Culturally-adapted and audio-technology assisted HIV/AIDS awareness and education program in rural Nigeria : a cohort study

enthalten in: BMC international health and human rights | 2010

von Ofotokun, I. | Binongo, J. | Rosenberg, E. | +4

74

Culturally-adapted and audio-technology assisted HIV/AIDS awareness and education program in rural Nigeria: a cohort study

enthalten in: BMC international health and human rights | 2010

von Ofotokun, I. | Binongo, J. | Rosenberg, E. | +4

75

Culturally-adapted and audio-technology assisted HIV/AIDS awareness and education program in rural Nigeria: a cohort study

enthalten in: BMC international health and human rights | 2010

von Ofotokun, I. | Binongo, J. | Rosenberg, E. | +4

76

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

in: Clinical Infectious Diseases | 2010

von Steigbige, R. | Cooper, D. | Teppler, H. | +19

77

Association between HLA-B*4001 and Lipodystrophy among HIV-Infected Patients from Thailand Who Received a Stavudine-Containing Antiretroviral Regimen - Stavudine-associated lipodystrophy is common among HIV-infected patients receiving stavudine-containing antiretroviral regimens in resource-limited settings. From this case-control, cross-sectional study, it was discovered that HLA-B*4001 was a strong genetic risk factor for developing stavudine-associated lipodystrophy in HIV-infected patients in Thailand.

enthalten in: Clinical infectious diseases | 2010

von Steigbigel, R. | Cooper, D. | Teppler, H. | +19

78

Clinical Science Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1-Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

enthalten in: Journal of acquired immune deficiency syndromes | 2010

von Lennox, J. | DeJesus, E. | Berger, D. | +14

79

Pandemic influenza : implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis

enthalten in: American journal of public health | 2009

von Heffelfinger, J. | Patel, P. | Brooks, J. | +15

80

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection : a multicentre, double-blind randomised controlled trial

enthalten in: Lancet (London, England) | 2009

von Lennox, J. | DeJesus, E. | Lazzarin, A. | +81

ErratumIn: Lancet. 2009 Dec 19-2010 Jan 1;374(9707):2054